Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

NCT00751751 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: olmesartan medoxomil + hydrochlorothiazide, if necessary
DRUG: losartan + hydrochlorothiazide, if necessary

Sponsor

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company